- 27.11.2024, Wednesday
- 14:48
Moderna's COVID-19 vaccine candidate moves into late-stage trial
News Service
14:4227/07/2020, Monday
U: 27/07/2020, Monday
REUTERS
Next article
File photo
Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said.
#Moderna
#vaccine
LEGAL NOTICE
The BIST name and logo are protected under the "Protected Trademark Certificate" and cannot be used, quoted, or altered without permission.All rights to the information disclosed under the BIST name are entirely owned by BIST and cannot be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.